Age between 18 and 78 year-old. 
Previous liver transplantation(more than 6 month). 
Genotype 1 and 4 infection. 
Hepatitis C recurrence defined by the presence of abnormal liver function test, positive HCV-RNA, histological signs of hepatitis C recurrence. 
Viral load ≥10000UI/mL. 
Immunosuppression with tacrolimus and/or mycophenolate (Prednisone use is allowed at low dose, ≤10 mg/d). 
Treatment naïve or treatment experienced (Peg-RBV or triple therapy). 
